1. Market Research
  2. > Therapy Industry

Chemotherapy Industry, January 2017 Market Reports from Top Publishers

You might be interested in: Therapy, Cancer, Colorectal Cancer, Breast Cancer, Pump, Lung Cancer, Prostate Cancer, Lymphoma, Brain Cancer, Hormone, Targeted Therapy, Gastric Cancer, Biosimilar, Bladder Cancer, Blood Disease, Cervical Cancer, Pancreatic Cancer, Anti-Infective, Leukemia, Nanomedicine.


 
1-10 of about 400 reports for Chemotherapy

Purchase Reports From Reputable Market Research Publishers

Chemotherapy Induced Neutropenia  - Epidemiology Forecast To 2023

Chemotherapy Induced Neutropenia  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Chemotherapy Induced Neutropenia  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Chemotherapy Induced Neutropenia  in seven major markets (US, France, ...

Chemotherapy Induced Nausea and Vomiting  - Epidemiology Forecast To 2023

Chemotherapy Induced Nausea and Vomiting  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight “Chemotherapy Induced Nausea and Vomiting  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Chemotherapy Induced Nausea and Vomiting  in seven majo ...

 Chemotherapy Induced Pain-Pipeline Insights, 2017

Chemotherapy Induced Pain-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Chemotherapy Induced Pain-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy Induced Pain. ...

 Chemotherapy Induced Neutropenia-Pipeline Insights, 2017

Chemotherapy Induced Neutropenia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Chemotherapy Induced Neutropenia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy Induced ...

 Chemotherapy Induced Nausea and Vomiting-Pipeline Insights, 2017

Chemotherapy Induced Nausea and Vomiting-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Chemotherapy Induced Nausea and Vomiting-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy ...

 Chemotherapy Induced Anemia-Pipeline Insights, 2017

Chemotherapy Induced Anemia-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Chemotherapy Induced Anemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy Induced ...

 Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2017

Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2017

  • $ 1250
  • Industry report
  • January 2017
  • by Delve Insight

DelveInsight’s, “ Chemotherapy Induced Peripheral Neuropathy-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Chemotherapy ...

Colon Cancer - Pipeline Review, H2 2016

Colon Cancer - Pipeline Review, H2 2016

  • $ 2500
  • Company report
  • December 2016
  • by Global Markets Direct

Colon Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer – Pipeline Review, H2 2016, provides an overview of ...

High-Grade Glioma - Pipeline Review, H2 2016

High-Grade Glioma - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • December 2016
  • by Global Markets Direct

High-Grade Glioma - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide High-Grade Glioma – Pipeline Review, H2 2016, provides an overview ...

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021

Global Chemotherapy-induced Nausea and Vomiting Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • December 2016
  • by Infiniti Research Limited

About CINV Drugs The launch of extended half-life drugs in the market is expected to substantially improve the adoption rates, owing to their ability to act for prolonged periods of time. For instance, ...

About 12000 reports for Chemotherapy

Download Unlimited Documents from Trusted Public Sources

Therapy Market in Australia

  • January 2016
    189 pages
  • Therapy  

    Cancer  

    Chemotherapy  

  • Australia  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.